Adverum Biotechnologies, Inc.
A Bioreactor Operator at Adverum executes pilot-scale bioreactor runs, prepares and manages bioreactor systems, and monitors critical process parameters to ensure optimal cell growth and product expression.
Headquarters
Redwood City, California, United States
Company Size
51-200 employees
Founded
2012
Adverum Biotechnologies is a clinical‑stage biotechnology company focused on developing ocular gene therapies to treat debilitating retinal diseases. The company aims to establish ocular gene therapy as a new standard of care by advancing in vivo gene‑delivery approaches (using viral vectors) to preserve or restore vision. Adverum advances multiple preclinical and clinical programs with an emphasis on translational science, regulatory engagement, and patient impact. Their tagline: "Redefining sight for life."
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Adverum Biotechnologies, Inc..
Adverum Biotechnologies, Inc. didn’t post a salary, so this is our estimate from similar listings.
139% above the average for this role
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
Oct 27, 2025
Upstream Process Development Scientist (Sunday-Thursday)
Eurofins
Upstream Process Development Scientist (Sunday-Thursday)
Eurofins
Upstream Scientist (Tues-Sat) - Temporary
Eurofins
Associate Development Scientist
Integrated Resources INC
Senior Scientist – Process Development
Avantor
Associate Development Scientist
Integrated Resources INC